Cannabis stocks rebound amid DEA rescheduling review

Stock Information for MedMen Enterprises Inc - Class B (Sub Voting)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MedMen Enterprises Inc - Class B (Sub Voting)

Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland
Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand
Aurora Announces Distribution Partnership with Leafio Australia
Rubicon Organics Announces Appointment of Glen Ibbott as CFO
Aurora Cannabis Announces Fiscal 2026 Second Quarter Results
Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call
Aurora Announces Investment into German Manufacturing Facility
Aurora and Copeia Launch English Version of Physician Experience Platform (PEP), Expanding Access to Peer-Reviewed Medical Cannabis Case Studies

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.